Background and Purpose: The aim of this research was to explore possible beneficial effects of blood transfusion for anemic terminal cancer patients with or without hospice care. Methods: Cancer patients admitted to a district hospital in the Hsintien area from January to April 2001 and who received blood transfusion were enrolled, and their clinical presentations were recorded. The post-transfusion presentation including any adverse reaction to the blood transfusion was also recorded. All patients were followed-up for 6 months. Results: There were only a few minor adverse reactions related to the transfusion. Both the non-hospice and hospice cancer patients reported improvement in symptoms, but the difference between the 2 groups was not significant. There was a significant difference in survival duration between the 2 groups (p<0.005). The non-hospice group survived longer. Conclusion: Blood transfusion can improve the symptoms related to anemia in cancer patients, and only a few adverse reactions to the transfusions were observed. Both groups showed similar degree of improvement with blood transfusion. According to our results, the decision to transfuse by a well-trained doctor and a terminal cancer patient should be respected.
Background and Purpose: The aim of this research was to explore possible beneficial effects of blood transfusion for anemic terminal cancer patients with or without hospice care. Methods: Cancer patients admitted to a district hospital in the Hsintien area from January to April 2001 and who received blood transfusion were enrolled, and their clinical presentations were recorded. The post-transfusion presentation including any adverse reaction to the blood transfusion was also recorded. All patients were followed-up for 6 months. Results: There were only a few minor adverse reactions related to the transfusion. Both the non-hospice and hospice cancer patients reported improvement in symptoms, but the difference between the 2 groups was not significant. There was a significant difference in survival duration between the 2 groups (p<0.005). The non-hospice group survived longer. Conclusion: Blood transfusion can improve the symptoms related to anemia in cancer patients, and only a few adverse reactions to the transfusions were observed. Both groups showed similar degree of improvement with blood transfusion. According to our results, the decision to transfuse by a well-trained doctor and a terminal cancer patient should be respected.
為了持續優化網站功能與使用者體驗,本網站將Cookies分析技術用於網站營運、分析和個人化服務之目的。
若您繼續瀏覽本網站,即表示您同意本網站使用Cookies。